3060 POSTER Final data from a large phase II trial of first-line bevacizumab plus classic or modified FOLFIRI in metastatic colorectal cancer (CRC)

✍ Scribed by A. Sobrero; S. Ackland; S. Clarke; R. Perez-Carrión; S. Chiara; J. Gapski; P. Mainwaring; M. Balcewicz; B. Langer; S. Young

• Book ID: 118625830
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 61 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70988-6